Search research articles
Contact Us
Filters
Showing results (121-130 of 133) with videos related to
Page
of 14
Sort By:
Molecular Cancer Therapeutics
|
May 28, 2015
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations
Mara A Bonelli, Andrea Cavazzoni, Francesca Saccani, et al.
Breast Cancer Research and Treatment
|
January 8, 2010
Synergistic activity of letrozole and sorafenib on breast cancer cells
Mara A Bonelli, Claudia Fumarola, Roberta R Alfieri, et al.
Cancer Chemotherapy and Pharmacology
|
November 22, 2013
Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinib
Marcello Tiseo, Massimo Ippolito, Maura Scarlattei, et al.
Molecular Cancer
|
December 14, 2012
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines
Andrea Cavazzoni, Roberta R Alfieri, Daniele Cretella, et al.
Oncotarget
|
May 28, 2015
NF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitor
Elena Galvani, Jing Sun, Leticia G Leon, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 15, 2023
PD-L1 overexpression induces STAT signaling and promotes the secretion of pro-angiogenic cytokines in non-small cell lung cancer (NSCLC)
A Cavazzoni, G Digiacomo, F Volta, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
August 16, 2011
Clinical and hemodynamic outcomes of "all-comers" undergoing transapical aortic valve implantation: results from the Italian Registry of Trans-Apical Aortic Valve Implantation (I-TA)
Augusto D'Onofrio, Paolo Rubino, Melissa Fusari, et al.
British Journal of Cancer
|
November 8, 2023
Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies
A Leonetti, M Verzè, R Minari, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 25, 2026
Targeting HGF/MET and CXCL1/CXCR2 axes bypasses resistance to KRAS<sup>G12C</sup> inhibitors in NSCLC
A Cavazzoni, M Pagano Mariano, A Palladini, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
May 27, 2008
Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Alec Vahanian, Ottavio R Alfieri, Nawwar Al-Attar, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 133) with videos related to
Sort By:
Page
of 14
Molecular Cancer Therapeutics
|
May 28, 2015
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations
Mara A Bonelli, Andrea Cavazzoni, Francesca Saccani, et al.
Breast Cancer Research and Treatment
|
January 8, 2010
Synergistic activity of letrozole and sorafenib on breast cancer cells
Mara A Bonelli, Claudia Fumarola, Roberta R Alfieri, et al.
Cancer Chemotherapy and Pharmacology
|
November 22, 2013
Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinib
Marcello Tiseo, Massimo Ippolito, Maura Scarlattei, et al.
Molecular Cancer
|
December 14, 2012
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines
Andrea Cavazzoni, Roberta R Alfieri, Daniele Cretella, et al.
Oncotarget
|
May 28, 2015
NF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitor
Elena Galvani, Jing Sun, Leticia G Leon, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 15, 2023
PD-L1 overexpression induces STAT signaling and promotes the secretion of pro-angiogenic cytokines in non-small cell lung cancer (NSCLC)
A Cavazzoni, G Digiacomo, F Volta, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
August 16, 2011
Clinical and hemodynamic outcomes of "all-comers" undergoing transapical aortic valve implantation: results from the Italian Registry of Trans-Apical Aortic Valve Implantation (I-TA)
Augusto D'Onofrio, Paolo Rubino, Melissa Fusari, et al.
British Journal of Cancer
|
November 8, 2023
Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies
A Leonetti, M Verzè, R Minari, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 25, 2026
Targeting HGF/MET and CXCL1/CXCR2 axes bypasses resistance to KRAS<sup>G12C</sup> inhibitors in NSCLC
A Cavazzoni, M Pagano Mariano, A Palladini, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
May 27, 2008
Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Alec Vahanian, Ottavio R Alfieri, Nawwar Al-Attar, et al.
Page
of 14